The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 2,970 | 100,500 | SH | Put | SOLE | 100,500 | 0 | 0 | |
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 2,970 | 100,500 | SH | Call | SOLE | 100,500 | 0 | 0 | |
| Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 17,730 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| Alector, Inc. | COM | 014442107 | 21,726 | 1,143,462 | SH | SOLE | 1,143,462 | 0 | 0 | ||
| Arbutus Biopharma Corporation | COM | 03879J100 | 1,265 | 608,151 | SH | SOLE | 608,151 | 0 | 0 | ||
| Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 28,261 | 245,424 | SH | SOLE | 245,424 | 0 | 0 | ||
| Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 18,816 | 429,690 | SH | SOLE | 429,690 | 0 | 0 | ||
| CymaBay Therapeutics, Inc. | COM | 23257D103 | 18,410 | 2,571,258 | SH | SOLE | 2,571,258 | 0 | 0 | ||
| Cytokinetics Incorporated | COM NEW | 23282W605 | 21,363 | 1,898,970 | SH | SOLE | 1,898,970 | 0 | 0 | ||
| Immunomedics, Inc. | COM | 452907108 | 5,350 | 385,751 | SH | SOLE | 385,751 | 0 | 0 | ||
| Insmed Incorporated | COM | 457669307 | 39,966 | 1,561,185 | SH | SOLE | 1,561,185 | 0 | 0 | ||
| Kiniksa Pharmaceuticals, Ltd. | Class A Common | G5269C101 | 866 | 63,922 | SH | SOLE | 63,922 | 0 | 0 | ||
| The Medicines Company | COM | 584688105 | 9,106 | 249,672 | SH | SOLE | 249,672 | 0 | 0 | ||
| Myokardia, Inc. | COM | 62857M105 | 12,909 | 257,452 | SH | SOLE | 257,452 | 0 | 0 | ||
| NGM Biopharmaceuticals, Inc. | COM | 62921N105 | 6,899 | 471,269 | SH | SOLE | 471,269 | 0 | 0 | ||
| OptiNose, Inc. | COM | 68404V100 | 17,857 | 2,522,189 | SH | SOLE | 2,522,189 | 0 | 0 | ||
| Replimune Group, Inc. | COM | 76029N106 | 18,012 | 1,228,656 | SH | SOLE | 1,228,656 | 0 | 0 | ||
| Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 10,329 | 469,482 | SH | SOLE | 469,482 | 0 | 0 | ||
| SI-BONE, Inc. | COM | 825704109 | 4,182 | 205,621 | SH | SOLE | 205,621 | 0 | 0 | ||
| Turning Point Therapeutics, Inc. | COM | 90041T108 | 74,492 | 1,830,265 | SH | SOLE | 1,830,265 | 0 | 0 | ||
| Veracyte, Inc. | COM | 92337F107 | 5,702 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| Voyager Therapeutics, Inc. | COM | 92915B106 | 14,611 | 536,771 | SH | SOLE | 536,771 | 0 | 0 | ||